ArticleJournal of gastrointestinal oncology2026
Association of serum lactate dehydrogenase levels with the severity of microvascular invasion in hepatocellular carcinoma: a retrospective cross-sectional study.
Article in Journal of gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Microvascular invasion (MVI) is an important factor affecting the prognosis of hepatocellular carcinoma (HCC) after hepatectomy. Current preoperative predictors, including alpha-fetoprotein (AFP) and imaging modalities, show limited sensitivity for identifying MVI, highlighting the need for additional accessible biomarkers. Glycolysis can produce lactic acid to promote cancer cell invasion, metastasis, and angiogenesis. Meanwhile, lactate dehydrogenase (LDH) can catalyze the conversion between lactate and pyruvate, is easily measurable, and may provide complementary value. We aim to explore the relationship between serum LDH levels and the severity of MVI in HCC patients. Methods: We retrospectively analyzed 621 HCC patients who underwent hepatectomy. Patients were stratified by the upper limit of normal (ULN) for serum LDH: group A (≤ ULN, n=461) and group B (> ULN, n=160). MVI was graded as M0, M1, or M2. The association between LDH level and MVI grade was assessed using Spearman's rank correlation. Variables with P<0.2 in univariate analysis were included in a multivariable ordinal logistic regression model to identify independent factors associated with MVI severity, adjusting for key clinicopathological confounders including tumor size, number, differentiation, and baseline liver function parameters. Statistical analyses were performed using SPSS version 25.0, with a two-tailed P<0.05 considered significant. Results: MVI grades were distributed as M0: 55.7% (n=346), M1: 27.2% (n=169), and M2: 17.1% (n=106). Median LDH was significantly higher in the M2 group (232 U/L) than in M1 (212 U/L, P=0.003) or M0 (196 U/L, P=0.007). A positive correlation was found between MVI grade and LDH level (r=0.212, P<0.001). The proportion of severe MVI (M2) was higher in group B (30.6%) than in group A (12.4%) (r=0.223, P<0.001). In multivariable ordinal logistic regression, LDH remained independently associated with higher MVI grade after adjustment for tumor burden and other covariates. ROC analysis showed limited discrimination of LDH for the presence of MVI (M1+M2) [area under the curve (AUC) =0.610]. Conclusions: Serum LDH is independently associated with MVI severity of HCC. Although the strength of association and discrimination is modest, LDH may provide complementary information to established predictors and could be considered as an adjunct variable in preoperative risk assessment models, pending further external and prospective validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.